.png)
Edaravone Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : December 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC127400
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Edaravone Market by Type (Injection, Oral) Application (Clinic, Hospital) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Edaravone Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Edaravone works by soothing the impacts of oxidative pressure, which might be identified with the passing of nerve cells in individuals with Amyotrophic Lateral Sclerosis (ALS). Keeping nerve cells sound may safeguard muscle function. Edaravone is utilized to treat amyotrophic sidelong sclerosis. Edaravone can cause genuine hypersensitive responses. Get crisis therapeutic assistance in the event that you have itching, swelling in your throat and face, hives, if you feel light-headed or trouble breathing.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Sun Pharmaceutical Industries Ltd.
- Mitsubishi Tanabe Pharma
- Unichem Laboratories Ltd
- Simcere
- UCB India Ltd
- Taj Pharmaceuticals Ltd.
- Piramal Healthcare
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Edaravone Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o Injection
o Oral
· Edaravone Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Clinic
o Hospital
· Edaravone Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Sun Pharmaceutical Industries Ltd.
o Mitsubishi Tanabe Pharma
o Unichem Laboratories Ltd
o Simcere
o UCB India Ltd
o Taj Pharmaceuticals Ltd.
o Piramal Healthcare
· Edaravone Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Edaravone Market , By Country
o U.S. Edaravone Market
o Canada Edaravone Market
o Mexico Edaravone Market
o Europe
§ Europe Edaravone Market , By Country
o Germany Edaravone Market
o UK Edaravone Market
o France Edaravone Market
o Russia Edaravone Market
o Italy Edaravone Market
o Rest of Europe Edaravone Market
o Asia-Pacific
§ Asia-Pacific Edaravone Market , By Country
o China Edaravone Market
o Japan Edaravone Market
o South Korea Edaravone Market
o India Edaravone Market
o Southeast Asia Edaravone Market
o Rest of Asia-Pacific Edaravone Market
o South America
§ South America Edaravone Market
o Brazil Edaravone Market
o Argentina Edaravone Market
o Columbia Edaravone Market
o Rest of South America Edaravone Market
o Middle East and Africa
§ Middle East and Africa Edaravone Market
o Saudi Arabia Edaravone Market
o UAE Edaravone Market
o Egypt Edaravone Market
o Nigeria Edaravone Market
o South Africa Edaravone Market
o Rest of MEA Edaravone Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Edaravone Market, By Type
5.1. Introduction
5.2. Global Edaravone Revenue and Market Share by Type (2017-2027)
5.2.1. Global Edaravone Revenue and Revenue Share by Type (2017-2027)
5.3. Injection
5.3.1. Global Injection Revenue and Growth Rate (2017-2027)
5.4. Oral
5.4.1. Global Oral Revenue and Growth Rate (2017-2027)
6. Edaravone Market, By Application
6.1. Introduction
6.2. Global Edaravone Revenue and Market Share by Application (2017-2027)
6.2.1. Global Edaravone Revenue and Revenue Share by Application (2017-2027)
6.3. Clinic
6.3.1. Global Clinic Revenue and Growth Rate (2017-2027)
6.4. Hospital
6.4.1. Global Hospital Revenue and Growth Rate (2017-2027)
7. Edaravone Market, By Region
7.1. Introduction
7.2. Global Edaravone Revenue and Market Share by Regions
7.2.1. Global Edaravone Revenue by Regions (2017-2027)
7.3. North America Edaravone by Countries
7.3.1. North America Edaravone Revenue and Growth Rate (2017-2027)
7.3.2. North America Edaravone Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Edaravone by Countries
7.4.1. Europe Edaravone Revenue and Growth Rate (2017-2027)
7.4.2. Europe Edaravone Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Edaravone by Countries
7.5.1. Asia-Pacific Edaravone Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Edaravone Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Edaravone by Countries
7.6.1. South America Edaravone Revenue and Growth Rate (2017-2027)
7.6.2. South America Edaravone Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Edaravone by Countries
7.7.1. Middle East and Africa Edaravone Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Edaravone Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Sun Pharmaceutical Industries Ltd.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Mitsubishi Tanabe Pharma
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Unichem Laboratories Ltd
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Simcere
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Unichem Laboratories Ltd
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Taj Pharmaceuticals Ltd
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Piramal Healthcare
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
9. Edaravone Market Forecast (2017-2027)
9.1. Global Edaravone Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Edaravone Market Forecast by Regions (2017-2027)
9.2.1. North America Edaravone Market Forecast (2017-2027)
9.2.1.1. United States Edaravone Market Forecast (2017-2027)
9.2.1.2. Canada Edaravone Market Forecast (2017-2027)
9.2.1.3. Mexico Edaravone Market Forecast (2017-2027)
9.2.2. Europe Edaravone Market Forecast (2017-2027)
9.2.2.1. Germany Edaravone Market Forecast (2017-2027)
9.2.2.2. France Edaravone Market Forecast (2017-2027)
9.2.2.3. UK Edaravone Market Forecast (2017-2027)
9.2.2.4. Russia Edaravone Market Forecast (2017-2027)
9.2.2.5. Italy Edaravone Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Edaravone Market Forecast (2017-2027)
9.2.3. Asia-Pacific Edaravone Market Forecast (2017-2027)
9.2.3.1. China Edaravone Market Forecast (2017-2027)
9.2.3.2. Japan Edaravone Market Forecast (2017-2027)
9.2.3.3. Korea Edaravone Market Forecast (2017-2027)
9.2.3.4. India Edaravone Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Edaravone Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Edaravone Market Forecast (2017-2027)
9.2.4. South America Edaravone Market Forecast (2017-2027)
9.2.4.1. Brazil Edaravone Market Forecast (2017-2027)
9.2.4.2. Argentina Edaravone Market Forecast (2017-2027)
9.2.4.3. Columbia Edaravone Market Forecast (2017-2027)
9.2.4.4. Rest of South America Edaravone Market Forecast (2017-2027)
9.2.5. Middle East and Africa Edaravone Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Edaravone Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Edaravone Market Forecast (2017-2027)
9.2.5.3. Egypt Edaravone Market Forecast (2017-2027)
9.2.5.4. Nigeria Edaravone Market Forecast (2017-2027)
9.2.5.5. South Africa Edaravone Market Forecast (2017-2027)
9.2.5.6. Turkey Edaravone Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Edaravone Market Forecast (2017-2027)
9.3. Edaravone Market Forecast by Type (2017-2027)
9.3.1. Edaravone Forecast by Type (2017-2027)
9.3.2. Edaravone Market Share Forecast by Type (2017-2027)
9.4. Edaravone Market Forecast by Application (2017-2027)
9.4.1. Edaravone Forecast by Application (2017-2027)
9.4.2. Edaravone Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Edaravone Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Edaravone Revenue and Revenue Share by Type (2017-2018)
Figure Global Injection Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Table Global Edaravone Revenue and Revenue Share by Application (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Table Global Edaravone Revenue by Regions (2017-2018)
Figure North America Edaravone Growth Rate (2017-2018)
Figure North America Edaravone Revenue and Growth Rate (2017-2018)
Figure North America Edaravone by Countries (2017-2018)
Figure North America Edaravone Revenue (Million USD) by Countries (2017-2018)
Figure United States Edaravone Growth Rate (2017-2018)
Figure United States Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Edaravone Growth Rate (2017-2018)
Figure Canada Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Edaravone Growth Rate (2017-2018)
Figure Mexico Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Edaravone Growth Rate (2017-2018)
Figure Europe Edaravone Revenue and Growth Rate (2017-2018)
Figure Europe Edaravone by Countries (2017-2018)
Figure Europe Edaravone Revenue (Million USD) by Countries (2017-2018)
Figure Germany Edaravone Growth Rate (2017-2018)
Figure Germany Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Edaravone Growth Rate (2017-2018)
Figure France Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Edaravone Growth Rate (2017-2018)
Figure UK Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Edaravone Growth Rate (2017-2018)
Figure Russia Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Edaravone Growth Rate (2017-2018)
Figure Italy Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Edaravone Growth Rate (2017-2018)
Figure Rest of Europe Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Edaravone Growth Rate (2017-2018)
Figure Asia-Pacific Edaravone Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Edaravone by Countries (2017-2018)
Figure Asia-Pacific Edaravone Revenue (Million USD) by Countries (2017-2018)
Figure China Edaravone Growth Rate (2017-2018)
Figure China Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Edaravone Growth Rate (2017-2018)
Figure Japan Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Edaravone Growth Rate (2017-2018)
Figure Korea Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Edaravone Growth Rate (2017-2018)
Figure India Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Edaravone Growth Rate (2017-2018)
Figure Southeast Asia Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Edaravone Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Edaravone Growth Rate (2017-2018)
Figure South America Edaravone Revenue and Growth Rate (2017-2018)
Figure South America Edaravone by Countries (2017-2018)
Figure South America Edaravone Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Edaravone Growth Rate (2017-2018)
Figure Brazil Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Edaravone Growth Rate (2017-2018)
Figure Argentina Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Edaravone Growth Rate (2017-2018)
Figure Columbia Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Edaravone Growth Rate (2017-2018)
Figure Rest of South America Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Edaravone Growth Rate (2017-2018)
Figure Middle East and Africa Edaravone Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Edaravone by Countries (2017-2018)
Figure Middle East and Africa Edaravone Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Edaravone Growth Rate (2017-2018)
Figure Saudi Arabia Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Edaravone Growth Rate (2017-2018)
Figure United Arab Emirates Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Edaravone Growth Rate (2017-2018)
Figure Egypt Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Edaravone Growth Rate (2017-2018)
Figure Nigeria Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Edaravone Growth Rate (2017-2018)
Figure South Africa Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Edaravone Growth Rate (2017-2018)
Figure Turkey Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Edaravone Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Edaravone Revenue (Millions USD) and Growth Rate (2017-2018)
Table Sun Pharmaceutical Industries Ltd. Edaravone Financial Overview
Table Mitsubishi Tanabe Pharma Edaravone Financial Overview
Table Unichem Laboratories Ltd Edaravone Financial Overview
Table Simcere Edaravone Financial Overview
Table Unichem Laboratories Ltd Edaravone Financial Overview
Table Taj Pharmaceuticals Ltd Edaravone Financial Overview
Table Piramal Healthcare Edaravone Financial Overview
Figure Global Edaravone Revenue (Millions USD) and Growth Rate (2018-2025)
Table Edaravone Market Forecast by Regions (2018-2025)
Figure North America Edaravone Market Forecast (2018-2025)
Figure United States Edaravone Market Forecast (2018-2025)
Figure Canada Edaravone Market Forecast (2018-2025)
Figure Mexico Edaravone Market Forecast (2018-2025)
Figure Europe Edaravone Market Forecast (2018-2025)
Figure Germany Edaravone Market Forecast (2018-2025)
Figure France Edaravone Market Forecast (2018-2025)
Figure UK Edaravone Market Forecast (2018-2025)
Figure Russia Edaravone Market Forecast (2018-2025)
Figure Italy Edaravone Market Forecast (2018-2025)
Figure Rest of Europe Edaravone Market Forecast (2018-2025)
Figure Asia-Pacific Edaravone Market Forecast (2018-2025)
Figure China Edaravone Market Forecast (2018-2025)
Figure Japan Edaravone Market Forecast (2018-2025)
Figure Korea Edaravone Market Forecast (2018-2025)
Figure India Edaravone Market Forecast (2018-2025)
Figure Southeast Asia Edaravone Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Edaravone Market Forecast (2018-2025)
Figure South America Edaravone Market Forecast (2018-2025)
Figure Brazil Edaravone Market Forecast (2018-2025)
Figure Argentina Edaravone Market Forecast (2018-2025)
Figure Columbia Edaravone Market Forecast (2018-2025)
Figure Rest of South America Edaravone Market Forecast (2018-2025)
Figure Middle East and Africa Edaravone Market Forecast (2018-2025)
Figure Saudi Arabia Edaravone Market Forecast (2018-2025)
Figure United Arab Emirates Edaravone Market Forecast (2018-2025)
Figure Egypt Edaravone Market Forecast (2018-2025)
Figure Nigeria Edaravone Market Forecast (2018-2025)
Figure South Africa Edaravone Market Forecast (2018-2025)
Figure Turkey Edaravone Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Edaravone Market Forecast (2018-2025)
Figure Global Edaravone Forecast by Type (2018-2025)
Figure Global Edaravone Market Share Forecast by Type (2018-2025)
Figure Global Edaravone Forecast by Type (2018-2025)
Figure Global Edaravone Forecast by Application (2018-2025)
Figure Global Edaravone Market Share Forecast by Application (2018-2025)
Figure Global Edaravone Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|